Biology of Blood and Marrow Transplantation
Volume 14, Issue 5 , Pages 568-575 , May 2008

Excellent Outcome of Allogeneic Hematopoietic Stem Cell Transplantation Using a Conditioning Regimen with Medium-Dose VP-16, Cyclophosphamide and Total-Body Irradiation for Adult Patients with Acute Lymphoblastic Leukemia

  • Akio Shigematsu

      Affiliations

    • Department of Hematology and Oncology, Hokkaido University Graduate School of Medicine, Sapporo, Japan
    • Corresponding Author InformationCorrespondence and reprint requests: Akio Shigematsu, MD, Hematology and Oncology, Hokkaido University Graduate School of Medicine, Kita-15 Nishi-7, Kita-ku, Sapporo, Hokkaido, 060-8638, Japan.
    • ,
  • Takeshi Kondo

      Affiliations

    • Department of Gastroenterology and Hematology, Hokkaido University Graduate School of Medicine, Sapporo, Japan
    • ,
  • Satoshi Yamamoto

      Affiliations

    • Department of Medicine II, Hokkaido University Graduate School of Medicine, Sapporo, Japan
    • ,
  • Junichi Sugita

      Affiliations

    • Department of Hematology and Oncology, Hokkaido University Graduate School of Medicine, Sapporo, Japan
    • ,
  • Masahiro Onozawa

      Affiliations

    • Department of Gastroenterology and Hematology, Hokkaido University Graduate School of Medicine, Sapporo, Japan
    • ,
  • Kaoru Kahata

      Affiliations

    • Department of Gastroenterology and Hematology, Hokkaido University Graduate School of Medicine, Sapporo, Japan
    • ,
  • Tomoyuki Endo

      Affiliations

    • Department of Medicine II, Hokkaido University Graduate School of Medicine, Sapporo, Japan
    • ,
  • Soichi Shiratori

      Affiliations

    • Department of Hematology and Oncology, Hokkaido University Graduate School of Medicine, Sapporo, Japan
    • ,
  • Shuichi Ota

      Affiliations

    • Department of Gastroenterology and Hematology, Hokkaido University Graduate School of Medicine, Sapporo, Japan
    • ,
  • Masato Obara

      Affiliations

    • Department of Medicine II, Hokkaido University Graduate School of Medicine, Sapporo, Japan
    • ,
  • Kentaro Wakasa

      Affiliations

    • Department of Hematology and Oncology, Hokkaido University Graduate School of Medicine, Sapporo, Japan
    • ,
  • Mutsumi Takahata

      Affiliations

    • Department of Gastroenterology and Hematology, Hokkaido University Graduate School of Medicine, Sapporo, Japan
    • ,
  • Yukari Takeda

      Affiliations

    • Department of Medicine II, Hokkaido University Graduate School of Medicine, Sapporo, Japan
    • ,
  • Junji Tanaka

      Affiliations

    • Department of Hematology and Oncology, Hokkaido University Graduate School of Medicine, Sapporo, Japan
    • ,
  • Satoshi Hashino

      Affiliations

    • Department of Gastroenterology and Hematology, Hokkaido University Graduate School of Medicine, Sapporo, Japan
    • ,
  • Mitsufumi Nishio

      Affiliations

    • Department of Medicine II, Hokkaido University Graduate School of Medicine, Sapporo, Japan
    • ,
  • Takao Koike

      Affiliations

    • Department of Medicine II, Hokkaido University Graduate School of Medicine, Sapporo, Japan
    • ,
  • Masahiro Asaka

      Affiliations

    • Department of Gastroenterology and Hematology, Hokkaido University Graduate School of Medicine, Sapporo, Japan
    • ,
  • Masahiro Imamura

      Affiliations

    • Department of Hematology and Oncology, Hokkaido University Graduate School of Medicine, Sapporo, Japan

Received 8 January 2008 ,Accepted 26 February 2008.

References 

  1. Hoelzer D, Thiel E, Löffler H, et al. Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults. Blood. 1988;71:123–131
  2. Larson RA, Dodge RK, Burns CP, et al. A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: Cancer and Leukemia Group B study 8811. Blood. 1995;85:2025–2037
  3. Durrant IJ, Prentice HG, Richards SM. Intensification of treatment for adults with acute lymphoblastic leukaemia: results of U.K. Medical Research Council randomized trial UKALL XA. Medical Research Council Working Party on Leukaemia in Adults. Br J Haematol. 1997;99:84–92
  4. Kantarjian HM, O'Brien S, Smith TL, et al. Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia. J Clin Oncol. 2000;18:547–561
  5. Annino L, Vegna ML, Camera A, et al. Treatment of adult acute lymphoblastic leukemia (ALL): long-term follow-up of the GIMEMA ALL 0288 randomized study. Blood. 2002;99:863–871
  6. Yanada M, Matsuo K, Suzuki T, et al. Allogeneic hematopoietic stem cell transplantation as part of postremission therapy improves survival for adult patients with high-risk acute lymphoblastic leukemia: a metaanalysis. Cancer. 2006;106:2657–2663
  7. Sebban C, Lepage E, Vernant JP, et al. Allogeneic bone marrow transplantation in adult acute lymphoblastic leukemia in first complete remission: a comparative study. French Group of Therapy of Adult Acute Lymphoblastic Leukemia. J Clin Oncol. 1994;12:2580–2587
  8. Horowitz MM, Messerer D, Hoelzer D, et al. Chemotherapy compared with bone marrow transplantation for adults with acute lymphoblastic leukemia in first remission. Ann Intern Med. 1991;115:13–18
  9. Hahn T, Wall D, Camitta B, et al. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute lymphoblastic leukemia in adults: an evidence-based review. Biol Blood Marrow Transplant. 2006;12:1–30
  10. Thomas X, Boiron JM, Huguet F, et al. Outcome of treatment in adults with acute lymphoblastic leukemia: analysis of the LALA-94 trial. J Clin Oncol. 2004;22:4075–4086
  11. Hunault M, Harousseau JL, Delain M, et al. Better outcome of adult acute lymphoblastic leukemia after early genoidentical allogeneic bone marrow tdransplantation (BMT) than after late high-dose therapy and autologous BMT: a GOELAMS trial. Blood. 2004;104:3028–3037
  12. Attal M, Blaise D, Marit G, et al. Consolidation treatment of adult acute lymphoblastic leukemia: a prospective, randomized trial comparing allogeneic versus autologous bone marrow transplantation and testing the impact of recombinant interleukin-2 after autologous bone marrow transplantation. BGMT Group. Blood. 1995;86:1619–1628
  13. Bostrom B, Weisdorf DJ, Kim T, et al. Bone marrow transplantation for advanced acute leukemia: a pilot study of high-energy total body irradiation, cyclophosphamide and continuous infusion etoposide. Bone Marrow Transplant. 1990;5:83–89
  14. Giralt SA, LeMaistre CF, Vriesendorp HM, et al. Etoposide, cyclophosphamide, total-body irradiation, and allogeneic bone marrow transplantation for hematologic malignancies. J Clin Oncol. 1994;12:1923–1930
  15. Petersen FB, Buckner CD, Appelbaum FR, et al. Etoposide, cyclophosphamide and fractionated total body irradiation as a preparative regimen for marrow trans-plantation in patients with advanced hematological malignancies: a phase 1 study. Bone Marrow Transplant. 1992;10:83–88
  16. Yau JC, LeMaistre CF, Andersson BS, et al. Allogeneic bone marrow transplantation for hematological malignancies following etoposide, cyclophosphamide, and fractionated total body irradiation. Am J Hematol. 1992;41:40–44
  17. Brown RA, Wolff SN, Fay JW, et al. High-dose etoposide, cyclophosphamide, and total body irradiation with allogeneic bone marrow transplantation for patients with acute myeloid leukemia in untreated first relapse: a study by the North American Marrow Transplant Group. Blood. 1995;85:1391–1395
  18. Brown RA, Wolff SN, Fay JW, et al. High-dose etoposide, cyclophosphamide and total body irradiation with allogeneic bone marrow transplantation for resistant acute myeloid leukemia: a study by the North American Marrow Transplant Group. Leuk Lymphoma. 1996;22:271–277
  19. Long GD, Amylon MD, Stockerl-Goldstein KE, et al. Fractionated total-body irradiation, etoposide, and cyclophosphamide followed by allogeneic bone marrow transplantation for patients with high-risk or advancedstage hematological malignancies. Biol Blood Marrow Transplant. 1997;3:324–330
  20. Spitzer TR, Peters C, Ortlieb M, et al. Etoposide in combination with cyclophosphamide and total body irradiation or busulfan as conditioning for marrow transplantation in adults and children. Int J Radiat Oncol Biol Phys. 1994;29:39–44
  21. Duerst RE, Horan JT, Liesveld JL, et al. Allogeneic bone marrow transplantation for children with acute leukemia: cytoreduction with fractionated total body irradiation, high-dose etoposide and cyclophosphamide. Bone Marrow Transplant. 2000;25:489–494
  22. Toubai T, Tanaka J, Mori A, et al. Efficacy of etoposide, cyclophosphamide, and total body irradiation in allogeneic bone marrow transplantation for adult patients with hematological malignancies. Clin Transplant. 2004;18:552–557
  23. Toubai T, Tanaka J, Ota S, et al. Minimal residual disease (MRD) monitoring using rearrangement of T-cell receptor and immunoglobulin H gene in the treatment of adult acute lymphoblastic leukemia patients. Am J Hematol. 2005;80:181–187
  24. Lee S, Kim DW, Kim YJ, et al. Influence of karyotype on outcome of allogeneic bone marrow transplantation for adults with precursor B-lineage acute lymphoblastic leukemia in first or second remission. Br J Haematol. 2002;117:109–118
  25. Dombret H, Gabert J, Boiron JM, et al. Groupe d'Etude et de Traitement de la Leucemie Aigue Lymphoblastique de l'Adulte (GET-LALA Group). Outcome of treatment in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia—results of the prospective multicenter LALA-94 trial. Blood. 2002;100:2357–2366
  26. Doney K, Hagglund H, Leisenring W, et al. Predictive factors for outcome of allogeneic hematopoietic cell transplantation for adult acute lymphoblastic leukemia. Biol Blood Marrow Transplant. 2003;9:472–481
  27. Doney K, Fisher LD, Appelbaum FR, et al. Treatment of adult acute lymphoblastic leukemia with allogeneic bone marrow transplantation. Multivariate analysis of factors affecting acute graft-versus-host disease, relapse, and relapse-free survival. Bone Marrow Transplant. 1991;7:453–459
  28. Woods WG, Nesbit ME, Ramsay NK, et al. Intensive therapy followed by bone marrow transplantation for patients with acute lymphocytic leukemia in second or subsequent remission: determination of prognostic factors (a report from the University of Minnesota Bone Marrow Transplantation Team). Blood. 1983;61:1182–1189
  29. Marks DI, Forman SJ, Blume KG, et al. A comparison of cyclophosphamide and total body irradiation with etoposide and total body irradiation as conditioning regimens for patients undergoing sibling allografting for acute lymphoblastic leukemia in first or second complete remission. Biol Blood Marrow Transplant. 2006;12:438–453
  30. Larson RA, Dodge RK, Burns CP, et al. A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811. Blood. 1995;85:2025–2037
  31. Ueda T, Miyawaki S, Asou N, et al. Response-oriented individualized induction therapy with 6 drugs followed by 4 courses of intensive consolidation, 1 year maintenance and intensification therapy: the ALL90 study of the Japan Adult Leukemia Study Group. Int J Hematol. 1998;68:279–289
  32. Pui CH, Relling MV. Topoisomerase II inhibitor-related acute myeloid leukaemia. Br J Haematol. 2000;109:13–23
  33. Pui CH, Ribeiro RC, Hancock ML, et al. Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia. N Engl J Med. 1991;325:1682–1687
  34. Hijiya N, Hudson MM, Lensing S, et al. Cumulative incidence of secondary neoplasms as a first event after childhood acute lymphoblastic leukemia. JAMA. 2007;297:1207–1215
  35. Pui CH, Sandlund JT, Pei D, et al. Total Therapy Study XIIIB at St. Jude Children's Research Hospital. Improved outcome for children with acute lymphoblastic leukemia: results of Total Therapy Study XIIIB at St. Jude Children's Research Hospital. Blood. 2004;104:2690–2696

PII: S1083-8791(08)00107-9

doi: 10.1016/j.bbmt.2008.02.018

Biology of Blood and Marrow Transplantation
Volume 14, Issue 5 , Pages 568-575 , May 2008

Article Tools

* Image Usage & Resolution